Stryker Logs Higher 4Q Profit On Sales Gains

By Amira McKee

Stryker posted higher profit in its fourth quarter, boosted by double-digit growth in medical and surgical equipment and neurotechnology sales.

The Portage, Mich.-based, medical supplies maker logged fourth-quarter profit of $849 million, or $2.20 per share, compared with $546 million, or $1.41 per share, a year earlier.

Adjusted earnings came in at $4.47 per share. Analysts polled by FactSet were expecting $4.06 per share.

Sales rose 11.4% to $7.17 billion, beating the $7.12 billion expected by Wall Street, according to FactSet. Organic sales increased 11% in the period, the company added.

MedSurg and neurotechnology sales increased 17.5% in the quarter to $4.6 billion, while orthopaedics sales grew 2.2% to $2.6 billion.

For the full year 2025, the company posted sales of $25.1 billion, up 11.2% from the year prior.

In 2026, Stryker expects full year organic net sales growth to be in the range of 8% to 9.5% and adjusted earnings to be in the range of $14.90 to $15.10 per share.

Analysts polled by FactSet are predicting 2026 adjusted earnings of $14.03 per share.

"Having surpassed $25 billion in revenue, we enter 2026 with significant momentum and are poised to continue delivering growth at the high end of MedTech," Chief Executive Officer Kevin A. Lobo said.

Write to Amira McKee at amira.mckee@wsj.com

(END) Dow Jones Newswires

January 29, 2026 17:05 ET (22:05 GMT)